A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma
Status:
Completed
Trial end date:
2018-08-22
Target enrollment:
Participant gender:
Summary
The purpose of the study is to demonstrate that it is possible to administer chemotherapy
prior to and following surgery for pancreatic cancer which is considered operable. The
chemotherapy chosen is that which has been shown to be the most effective in treating
metastatic disease, and the goal is both to investigate whether this is tolerable and also to
investigate the efficacy of this approach in terms of disease response and survival.